Trophogen, Inc. is a biotechnology company founded in 2001, focusing on the development of high affinity glycoprotein hormone and related growth factor analogs for targeted therapy and imaging of ovarian, breast, prostate, testicular and thyroid cancers as well as for human and animal infertility.
Contact Trophogen:
